ID1 Randomised Prospective Study Comparing Cost-Effectiveness of Teicoplanin and Vancomycin As Second-Line Empiric Therapy for Infection in Neutropenic Patients
May 1, 1998, 00:00
10.1046/j.1524-4733.1998.1100371.x
https://www.valueinhealthjournal.com/article/S1098-3015(10)75608-4/fulltext
Title :
ID1 Randomised Prospective Study Comparing Cost-Effectiveness of Teicoplanin and Vancomycin As Second-Line Empiric Therapy for Infection in Neutropenic Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75608-4&doi=10.1046/j.1524-4733.1998.1100371.x
First page :
Section Title :
Open access? :
No
Section Order :
30